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Abstract
Background: Effective national and global HIV responses require a significant expansion of HIV testing and counselling
(HTC) to expand access to prevention and care. Facility-based HTC, while essential, is unlikely to meet national and global
targets on its own. This article systematically reviews the evidence for community-based HTC.
Methods and Findings: PubMed was searched on 4 March 2013, clinical trial registries were searched on 3 September 2012,
and Embase and the World Health Organization Global Index Medicus were searched on 10 April 2012 for studies including
community-based HTC (i.e., HTC outside of health facilities). Randomised controlled trials, and observational studies were
eligible if they included a community-based testing approach and reported one or more of the following outcomes: uptake,
proportion receiving their first HIV test, CD4 value at diagnosis, linkage to care, HIV positivity rate, HTC coverage, HIV
incidence, or cost per person tested (outcomes are defined fully in the text). The following community-based HTC
approaches were reviewed: (1) door-to-door testing (systematically offering HTC to homes in a catchment area), (2) mobile
testing for the general population (offering HTC via a mobile HTC service), (3) index testing (offering HTC to household
members of people with HIV and persons who may have been exposed to HIV), (4) mobile testing for men who have sex
with men, (5) mobile testing for people who inject drugs, (6) mobile testing for female sex workers, (7) mobile testing for
adolescents, (8) self-testing, (9) workplace HTC, (10) church-based HTC, and (11) school-based HTC. The Newcastle-Ottawa
Quality Assessment Scale and the Cochrane Collaboration’s ‘‘risk of bias’’ tool were used to assess the risk of bias in studies
with a comparator arm included in pooled estimates.
117 studies, including 864,651 participants completing HTC, met the inclusion criteria. The percentage of people offered
community-based HTC who accepted HTC was as follows: index testing, 88% of 12,052 participants; self-testing, 87% of
1,839 participants; mobile testing, 87% of 79,475 participants; door-to-door testing, 80% of 555,267 participants; workplace
testing, 67% of 62,406 participants; and school-based testing, 62% of 2,593 participants. Mobile HTC uptake among key
populations (men who have sex with men, people who inject drugs, female sex workers, and adolescents) ranged from 9%
to 100% (among 41,110 participants across studies), with heterogeneity related to how testing was offered. Community-
based approaches increased HTC uptake (relative risk [RR] 10.65, 95% confidence interval [CI] 6.27–18.08), the proportion of
first-time testers (RR 1.23, 95% CI 1.06–1.42), and the proportion of participants with CD4 counts above 350 cells/ml (RR 1.42,
95% CI 1.16–1.74), and obtained a lower positivity rate (RR 0.59, 95% CI 0.37–0.96), relative to facility-based approaches. 80%
(95% CI 75%–85%) of 5,832 community-based HTC participants obtained a CD4 measurement following HIV diagnosis, and
73% (95% CI 61%–85%) of 527 community-based HTC participants initiated antiretroviral therapy following a CD4
measurement indicating eligibility. The data on linking participants without HIV to prevention services were limited. In low-
and middle-income countries, the cost per person tested ranged from US$2–US$126. At the population level, community-
based HTC increased HTC coverage (RR 7.07, 95% CI 3.52–14.22) and reduced HIV incidence (RR 0.86, 95% CI 0.73–1.02),
although the incidence reduction lacked statistical significance. No studies reported any harm arising as a result of having
been tested.
Conclusions: Community-based HTC achieved high rates of HTC uptake, reached people with high CD4 counts, and linked
people to care. It also obtained a lower HIV positivity rate relative to facility-based approaches. Further research is needed to
further improve acceptability of community-based HTC for key populations. HIV programmes should offer community-
based HTC linked to prevention and care, in addition to facility-based HTC, to support increased access to HIV prevention,
care, and treatment.
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Introduction
HIV is a leading cause of morbidity and mortality globally [1].
Despite considerable progress in controlling the epidemic, there
were approximately 2.2 million new HIV infections, 1.7 million
HIV-related deaths, and 34.2 million people with HIV
worldwide in 2011; 1.5 million of these new HIV infections,
1.2 million of the HIV deaths, and 23.5 million of the people
living with HIV were in Africa [2]. Given the urgency to act on
the epidemic, all United Nations member states agreed to
achieve the following HIV targets by 2015: (1) reduce sexual and
parenteral HIV transmission by 50%, (2) eliminate vertical HIV
transmission, (3) reduce tuberculosis deaths among people with
HIV by 50%, and (4) deliver antiretroviral therapy (ART) to 15
million people [3]. Achieving these targets will require people at
risk of HIV to learn their status and link to prevention and care
services.
In an effort to expand access to prevention and care services,
World Health Organization (WHO) guidelines recommend
provider-initiated HIV testing and counselling (HTC) for all
people seen in all health facilities in generalised epidemics (i.e.,
antenatal HIV prevalence $1%) and in specific facilities in
concentrated epidemics [4]. While provider-initiated HTC pro-
grammes have been successful in identifying previously undiag-
nosed individuals in generalised epidemics, they may not reach all
people at risk of HIV acquisition [5,6]. Indeed, the latest
Demographic and Health Surveys from 29 sub-Saharan African
countries, representing approximately half of the global burden of
HIV, indicate that only 15% of adults received results from an
HIV test in the previous year [7]. This low coverage is recognised
as a critical barrier to scaling up HIV prevention and care
interventions. Furthermore, people living with HIV are often
diagnosed late in the course of their disease, resulting in avoidable
morbidity, mortality, and transmission of the virus. [8].
The reasons for the current low coverage of HTC are various
and include service, patient, and demographic barriers [9,10].
For example, in generalised epidemics women have higher rates
of testing than men and adolescents, perhaps because of their
contact with reproductive and antenatal health services [7].
Implementation of provider-initiated HTC guidance remains a
priority for countries. However, because many people have
limited contact with healthcare providers, HTC provision in
health facilities alone is insufficient to achieve national and global
targets. Although previous research has reviewed home-based
HTC [11,12], the impact of all community-based HTC
approaches has not been systematically reviewed. The objective
of this study was to systematically review all community-
based HTC approaches to inform global and national HIV
programming.
Methods
Conduct of Systematic Review
This systematic review was conducted in accordance with the
PRISMA statement using a pre-defined protocol (International
Prospective Register of Systematic Reviews identification num-
ber: CRD42012002554; Text S1 and Protocol S1) [13,14]. The
PubMed database was searched on 4 March 2013, and Embase
and WHO Global Index Medicus were systematically searched
on 10 April 2012, without language, geographic, publication,
date, or any other restrictions. In addition, the WHO Interna-
tional Clinical Trials Registry Platform, the Cochrane Central
Register of Controlled Trials, the International Standard
Randomised Controlled Trial Number Register, and Clinical-
Trials.gov were systematically searched without language, pub-
lication, or date restrictions on 3 September 2012. Experts in the
field were contacted to identify unpublished research and
ongoing studies, and bibliographies of relevant studies were
screened.
Study Definitions
Community-based HTC was defined as HTC outside of health
facilities. Facility-based HTC approaches were defined as those in
healthcare sites (e.g., health facilities, hospitals, and fixed, stand-
alone voluntary counselling and testing sites). Eleven different
community-based HTC approaches were reviewed in this study:
(1) door-to-door testing (systematically offering HTC to homes in a
catchment area), (2) mobile testing for the general population
(offering HTC via a mobile HTC service in areas visited by the
general public, such as shopping centres, transport hubs, or
roadside restaurants), (3) index testing (offering HTC to household
members of people with HIV and persons who may have been
exposed to HIV such as spouses, sexual partners, or children of
people with HIV); (4) mobile testing for men who have sex with
men (MSM), (5) mobile testing for people who inject drugs
(PWID), (6) mobile testing for female sex workers (FSW), (7)
mobile testing for adolescents, (8) self-testing, (9) workplace HTC,
(10) church-based HTC, and (11) school-based HTC.
Several outcomes were analysed in this study. Uptake was
calculated by dividing the number of individuals accepting HTC
by the number of individuals offered HTC. The proportion of
first-time testers was calculated by dividing the number of people
reporting receiving their first HIV test by the total number of
people tested. The proportion of participants with a CD4 count
greater than 350 cells/ml was calculated among participants with
HIV who had their CD4 count measured. Two steps of the
retention continuum were assessed: (1) CD4 measurement
(among all participants found to have HIV) and (2) initiation of
ART (among participants eligible per national guidelines). In
Community-based HIV Testing and Counselling
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studies with a comparator arm, the HIV positivity rate was
calculated by dividing the number of individuals found to be HIV
positive by the number of individuals tested. HTC coverage was
calculated by dividing the number of people tested by the total
number of people living in the catchment area for the
community-based HTC approach. HIV incidence was calculat-
ed by dividing the risk of infection in communities with access to
community- and facility-based HTC by the risk of infection in
communities with access to only facility-based HTC. Some of the
outcomes were not independent. For example, the number of
people tested was the denominator for the HIV positivity rate
and first-time testers and also the numerator for HTC coverage.
Moreover, the number of people living with HIV was the
numerator for the HIV positivity rate and also the denominator
for calculating the first step of the retention continuum (CD4
measurement). The cost per person tested was approximated by
dividing the economic costs incurred during HTC in studies by
the total number of people tested. Costs were adjusted for
































































































































































































































































































































































































































































































































































































































































































































































































Figure 1. Flow of information through different phases of the
review.
doi:10.1371/journal.pmed.1001496.g001
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States dollars using the US Bureau of Labor Statistics’ inflation
calculator [15].
Search Strategy and Selection Criteria
The search strategies (Table S1) were designed with the
assistance of a librarian to identify studies including community-
based HTC. Following recommendations from PRISMA,
eligibility criteria were based on key study characteristics:
population, intervention, comparator, outcome, and design
[13]. Specifically, studies were included when (1) the study
population included people in generalised, concentrated, or low-
level HIV epidemics; (2) the intervention was community-based
HTC offered in combination with a background of facility-based
HTC; (3) the comparator was facility-based HTC; (4) the
outcome(s) included uptake, proportion of people reporting
receiving their first HIV test, CD4 value at diagnosis, rates of
linkage to care, HIV positivity rate, HTC coverage, HIV
incidence, or cost per person tested; and (5) the study design was
a randomised trial or observational cohort study. Given the lack
of comparative studies for community-based HTC, studies
without a comparator arm were also included if they met the
remaining eligibility criteria.
A. B. S., N. F., and O. A. independently screened the abstracts
of all articles identified via the literature database searches and
then compared the full texts of all articles selected during screening
against the inclusion criteria. Disagreements were resolved by
discussion. J. S. R. and A. K. S. repeated the same process for the
clinical trial registries.
Data Extraction
A. B. S., J. S. R., and A. K. S. completed the data extraction of
characteristics of study participants, community-based testing
approaches, outcomes, and quality assessment using a standard-
ised extraction form.
Table 2. Percentage of clients received as couples in community-wide testing efforts.
Study (Testing Approach) Country Year






Sweat (facility-based) [23] Thailand 2007 1,472 2,721 54.1%
Sweat (mobile) [23] Thailand 2007 2,574 10,464 24.6%
Tumwesigye (door-to-door) [74] Uganda 2007 35,634 264,966 13.4%
Sweat (facility-based) [23] Zimbabwe 2007 61 610 10.0%
Naik (door-to-door) [70] South Africa 2010 458 5,086 9.1%
Lugada (mobile) [56] Kenya 2008 3,296 47,173 7.0%
Sweat (facility-based) [23] Tanzania 2007 24 685 3.5%
Sweat (mobile) [23] Zimbabwe 2007 223 6,579 3.4%
Sweat (mobile) [23] Tanzania 2007 54 2,832 1.9%
doi:10.1371/journal.pmed.1001496.t002
Figure 2. Pooled uptake of community-based HTC approaches. Bars indicate 95% CIs.
doi:10.1371/journal.pmed.1001496.g002
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Quality Assessment
The Newcastle-Ottawa Quality Assessment Scale was used to
assess bias in studies with a comparator arm included in pooled
analyses [16]. This scale rates studies based on eight criteria in
three sources of bias. We modified this scale to remove one
criterion, demonstration that the outcome of interest was not
present at the start of study, since a previous HIV test may not
affect all the outcomes analysed in this article. The Cochrane
Collaboration’s ‘‘risk of bias’’ tool was used to assess bias in
randomised trials with a comparator arm [17].
Statistical Analyses
Outcome proportions from studies meeting inclusion criteria
were stabilised using the Freeman-Tukey-type arcsine square-root
transformation and then pooled to summarise the proportion of
Figure 3. Uptake of index HTC.
doi:10.1371/journal.pmed.1001496.g003
Figure 4. Uptake of self-testing.
doi:10.1371/journal.pmed.1001496.g004
Figure 5. Uptake of mobile HTC.
doi:10.1371/journal.pmed.1001496.g005
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participants who (1) accepted different community-based HTC
approaches, (2) reported receiving their first HIV test, (3) had CD4
counts measured after diagnosis, (4) were diagnosed with HIV with
a CD4 count above 350 cells/ml, and (5) initiated ART after their
CD4 count indicated they were eligible for treatment [18,19].
Pooled relative risks (RRs) were used to compare participants of
community- and facility-based HTC with respect to uptake,
proportion of first-time testers, the HIV positivity rate, proportion
with CD4 counts above 350 cells/ml, and HTC coverage.
Random-effects models were used for all analyses. Given the
differences in HIV epidemiology, sexual mixing patterns, trans-
mission factors, and healthcare utilisation rates for key popula-
Figure 6. Uptake of door-to-door HTC. Asterisk: data reported were exclusively from children aged 18 mo.–13 y.
doi:10.1371/journal.pmed.1001496.g006
Figure 7. Uptake of workplace HTC. Asterisk: data reported were from the Democratic Republic of Congo, Rwanda, Burundi, Congo, and Nigeria.
doi:10.1371/journal.pmed.1001496.g007
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tions, key population outcome data were reported individually and
not pooled. I2 statistics were used to measure heterogeneity [20]. I2
statistics near 25% indicate low heterogeneity, values near 50%
indicate moderate heterogeneity, and those above 75% indicate




108 articles, describing studies conducted from 1987 to 2012
and including 864,651 participants completing HTC, met the
eligibility criteria (Table 1; Figure 1). Two articles were
randomised trials [22,23], and the rest were observational in
design. Data from one multi-centre cluster-randomised trial were
stratified into three studies (based on the country where the testing
was offered) [23], data from three articles were stratified based on
the year community-based HTC was offered [24–26], and data
from four articles were stratified based on the community-based
HTC approach used [27–30]. Given that 108 articles provided
data from 108 studies and there were nine additional studies after
stratification, there were a total of 117 studies included (Table S4).
76 studies were from Africa, 28 were from North America
(excluding Central America), six were from Asia, four were from
Central and South America, three were from Europe, and one was
from Australia. The clinical trial registers identified ten ongoing
trials: one on index testing [31], one on mobile testing [32], five on
door-to-door testing [33–37], one on self-testing [38], and two on
community-based testing for key populations [39,40].
The percentage of participants who were male was 45.3% for
index testing, 45.9% for door-to-door testing, 44.9% for mobile
testing, 62.6% for self-testing, 67.0% for workplace testing, and
42.2% for school-based testing (Table 1). Excluding studies
including only MSM or only FSW, 62.9% of testers were male
in mobile testing for key populations (Table 1). Population-level
HTC efforts found that implementation of community-based
HTC increases the number of couples receiving testing (Table 2).
Uptake
61 studies reported uptake of different community-based testing
approaches among 713,632 participants: seven studies evaluated
index testing among 12,052 participants [29,30,41–46], three
evaluated self-testing among 1,839 participants [47–49], 14
evaluated mobile HTC among 79,475 participants [26,28,50–
59], 28 evaluated door-to-door testing among 555,267 participants
[24,25,28,30,60–81], six evaluated workplace HTC among 62,406
participants [22,82–86], and three evaluated school-based HTC
among 2,593 participants [87–89] (Figure 2). The percentage of
participants accepting HTC was 88.2% for index testing (95%
confidence interval [CI] 80.5%–95.9%; I2 99.7%, 95% CI 99.7%–
99.8%; Figure 3), 87.1% for self-testing (95% CI 85.1%–89.0%; I2
28.8%, 95% CI 0%–92.6%; Figure 4), 86.8% for mobile HTC
(95% CI 85.6%–88.1%; I2 99.9%, 95% CI 99.9%–99.9%;
Figure 5), 80.0% for door-to-door HTC (95% CI 76.9%–83.1%;
I2 99.9%, 95% CI 99.9%–99.9%; Figure 6), 67.4% for workplace
HTC (95% CI 32.8%–100.0%; I2 100%, 100.0%–100.0%;
Figure 7), and 62.1% for school-based HTC (95% CI 39.6%–
84.5%; I2 99.0%, 95% CI 98.5%–99.4%; Figure 8). Uptake was
higher in community-based HTC compared to providing vouchers
to participants for facility-based HTC (RR 10.65, 95% CI 6.27–
18.08; I2 96.1%; Figure 9) [22,43].
19 studies reported uptake among 41,110 participants in key
populations, including 16,725 MSM [90–97], 4,681 PWID
[92,98–100], 81 FSW [101], 13,240 adolescents [102,103], and
6,383 individuals from combinations of key populations. The
percentage accepting HTC was 99.7% among FSW, ranged from
13.7% to 94.5% among PWID, ranged from 9.4% to 95.0%
among MSM, and ranged from 33.9% to 96.6% among
adolescents (Figure 10). One study reported an uptake percentage
of 95.2% among PWID and FSW [104], another reported an
uptake percentage of 75.1% among PWID, FSW, and MSM
[105], and another reported an uptake percentage of 60.0%
among PWID and MSM [106]. Uptake was higher for commu-
nity-based testing than for facility-based testing among FSW (RR
1.10, 95% CI 1.03–1.17) [101] and MSM (RR 1.53, 95% CI
1.42–1.65) [96] (Figure 11).
First-Time Testers
33 studies reported the HTC history among 597,016 partic-
ipants in community-based HTC approaches [23,25,27–
29,44,47,51,53–55,58–61,63,64,69,70,72,74,83,107–112]. 62.2%
(95% CI 58.0%–66.4%; I2 99.9%, 95% CI 99.9%–99.9%;
Figure 12) of participants at community-based HTC sites
reported receiving their first HIV test. In the nine studies with
a facility-based comparator arm, a larger proportion of partic-
ipants reported receiving their first HIV test at community-based
HTC than at facility-based HTC (RR 1.23, 95% CI 1.06–1.42; I2
99.8%, 95% CI 99.8%–99.9%; Figure 9) [23,27,29,107,108,111].
17 studies reported the HTC history of 25,311 participants from
key populations receiving community-based HTC [27,90,92,94,
96,98,105,108,113–118]. 9% to 79% of participants reported
receiving their first HIV test (Figure 13). Five of these studies
included a facility-based comparator arm (Figure 11). There were
more first-time testers in community-based HTC than facility-
based HTC for two study populations of MSM (RR 2.24, 95% CI
1.27–3.93 [113] and RR 1.37, 95% CI 1.18–1.59 [108]); however,
there were fewer first-time testers in community-based HTC for a
different study population of MSM (RR 0.33, 95% CI 0.26–0.43
[96]). There were more first-time testers in community-based
HTC than facility-based HTC for a study population including
PWID and MSM (RR 1.10, 95% CI 1.08–1.13 [116]); however,
there was no difference in the proportion of first-time testers for a
study population of FSW (RR 0.97, 95% CI 0.72–1.30 [108]).
Figure 8. Uptake of school-based HTC.
doi:10.1371/journal.pmed.1001496.g008
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HIV Positivity Rate
14 studies included data on the HIV positivity rate among
people testing in community-based approaches relative to people
testing in facility-based approaches [22,23,27,29,43,62,87,108,
119–121]. Overall, the HIV positivity rate was lower in
community-based approaches relative to facility-based approaches
(RR 0.59, 95% CI 0.37–0.96; I2 99.6%, 95% CI 99.6%–99.7%;
Figure 9). The median number needed to screen to identify one
person with HIV in community- and facility-based HTC was 17
(range 3–86) and 6 (range 4–154), respectively (Table 3). The
number needed to screen with community-based testing was
highest in settings with a low national HIV prevalence: 54 in
Thailand and 86 in Guatemala [23,108].
Six community-based testing studies for key populations
included a facility-based comparator arm (Figure 11). Studies
including FSW and a combination of PWID and MSM found no
difference in the positivity rate for community- versus facility-
based approaches (FSW, RR 0.62, 95% CI 0.29–1.34 [108] and
RR 1.39, 95% CI 0.85–2.29 [101]; PWID and MSM, RR 1.13,
95% CI 0.91–1.39 [116]). There was a lower positivity rate among
a study population of MSM (RR 0.09, 95% CI 0.03–0.33 [108])
and among a study population including PWID, FSW, and MSM
Figure 9. Pooled relative risks of community-based HTC versus facility-based HTC. The numerator for all RRs was the risk of an outcome in
community-based testing, while the denominator was the risk of an outcome in facility-based testing.
doi:10.1371/journal.pmed.1001496.g009
Community-based HIV Testing and Counselling
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(RR 0.51, 95% CI 0.28–0.94 [122]). There was also a higher
positivity rate among a study population of MSM (RR 2.37, 95%
CI 1.35–4.15 [123]). The number needed to screen to identify one
person with HIV varied depending on the key population and
study setting (Table 4).
CD4 Counts
18 studies reported the CD4 counts of 8,993 participants found
to be HIV-positive using point-of-care or standard lab diagnostics
[29,30,51,55,56,60,61,74,76,82,110,121,124–127]. 56.7% (95%
CI 49.6%–63.9%; I2 97.6%, 95% CI 97.0%–98.1%; Figure 14)
of participants testing positive had CD4 counts above 350 cells/ml.
In the five studies with a facility-based HTC comparator arm,
more participants in community-based HTC approaches had
CD4 counts above 350 cells/ml than in facility-based approaches
(RR 1.42, 95% CI 1.16–1.74; I2 94.8%, 95% CI 90.5%–97.1%;
Figure 9) [29,121,125,127].
Two studies reported the CD4 counts of participants found to
be HIV-positive in a key population. Using standard lab
diagnostics these studies reported a median CD4 count of 550
cells/ml among MSM [115] and 385 cells/ml among MSM,
PWID, and FSW [105].
Linkage to Care
17 studies, including 5,852 participants with HIV, reported
linkage to care from HIV diagnosis to CD4 measurement
[30,51,55,60,61,76,82,86,89,110,124–126,128,129]. Overall,
80.1% of participants had their CD4 count measured after HIV
diagnosis (95% CI 74.8%–85.4%; I2 99.5%, 95% CI 99.4%–
99.5%; Figure 15). Nine studies with 527 participants reported
Figure 10. Uptake of community-based HTC approaches among key populations.
doi:10.1371/journal.pmed.1001496.g010
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linkage to care from being eligible to ART to initiating ART
[30,61,76,82,89,124,129]. Overall, 73.1% of participants initiated
ART after their CD4 count indicated that they were eligible (95%
CI 61.3%–84.9%; I2 96.9%, 95% CI 95.6%–97.9%; Figure 15).
Two studies, including 52 participants with HIV, reported
linkage to care from HIV diagnosis to CD4 measurement in key
populations. 12 of 15 MSM had their CD4 count measured after
HIV diagnosis [115]. 26 of 37 MSM and/or PWID had their CD4
count measured after HIV diagnosis [105]. No studies reported
linkage to care from being eligible for ART to initiating ART in
key populations.
Coverage
14 studies summarised HTC coverage among all people living
in the testing site’s catchment area [23,51,56,63,70,71,74,81].
Coverage of HTC ranged from 5% to 93% depending on the type
of approach used (Table 5). Mobile HTC available as part of
multi-disease health campaigns achieved high coverage in the
shortest period of time. Community-based HTC increased
coverage of HTC relative to facility-based approaches (RR 7.07,
95% CI 3.52–14.22; I2 99.7%, 95% CI 99.7%–99.8%; Figure 9).
HIV Incidence
One study reported HIV incidence [130]. There was a
decreased risk of HIV infection in communities randomised to
community-based testing relative to communities randomised to
facility-based testing, although this estimate lacked statistical
significance (RR 0.86, 95% CI 0.73–1.02; Figure 9).
Cost per Person Tested
The cost per person tested ranged from US$2.45 to US$881.63
using different community-based testing approaches (Table 6)
[29,45,71,74,107,117,122,131–136]. The cost per person tested
was US$2.45 to US$14.37 for door-to-door testing, US$3.26 to
US$33.54 for mobile testing, US$12.91 for hospital testing,
US$15.30 to US$203.04 for index testing, US$21.28 to
US$29.56 for testing at a fixed HTC site, US$126.48 for
church-based testing, US$92.83 to US$881.63 for community-
based testing for key populations, and US$93.73 for testing at an
HIV clinic. Due to the heterogeneity in health systems and HIV
prevalence within and between countries, the cost per person
identified with HIV was not included.
Potential Harms
No studies reported harm arising as a result of having been
tested. 18 studies gave a description of the testers’ experiences or
listed reasons for tester refusal [47–49,52,58,64,71,81,
82,91,102,109,113,115,137–139]. The studies discussed both the
clients’ positive testing experiences and their fears. Eight studies
(including one targeting key populations) reported instances where
participants refused HTC because of fear of status disclosure or
stigma [52,58,64,71,81,82,102,109]. In contrast, 12 studies
(including three studies targeting key populations) specifically
reported either no evidence of harm [47–49,55,91,113,115] or
benefit through improved privacy or reduced stigma and fear
[52,82,137–139].
Quality Assessment
There was concern of selection bias in nine of the studies
included in pooled analyses [22,23,62,111,119,125], concern of
confounding in five studies [27,62,108,111,119], and concern of
measurement bias in five studies [81,107,111,121,127] (Table
S2). The randomised trials appeared to have limited selection,
attrition, and reporting bias; however, their lack of blinding made
them susceptible to performance and detection bias [22,23]
(Table S3).
Sensitivity Analyses
While there was high uptake for community-based approaches
in most studies, there were several outliers with low uptake. To
gauge whether these outliers influenced pooled uptake estimates
and increased heterogeneity we conducted sensitivity analyses
without them (Table 7). Although the pooled estimates increased
and the CIs tightened without the outliers, there was still high
heterogeneity using the I2 statistic. There was potential for
selection bias, confounding, and measurement bias in several of
the observational studies identified (Table S2). To determine
whether these studies introduced bias into our results we ran
Figure 11. Relative risks of community-based HTC versus facility-based HTC among key populations. The numerator for all RRs was the
risk of an outcome in community-based testing, while the denominator was the risk of an outcome in facility-based testing.
doi:10.1371/journal.pmed.1001496.g011
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Figure 12. First-time testers in community-based testing approaches.
doi:10.1371/journal.pmed.1001496.g012
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sensitivity analyses without them and found the results to be
similar (Table 8).
Discussion
This systematic review found that community-based HTC
approaches were successful in reaching populations early in the
course of HIV infection. The studies with facility-based compar-
ator arms further suggest that community-based HTC reached
populations earlier in the course of HIV infection than facility-
based HTC. Earlier HIV diagnosis supports timely access to ART,
which could improve life expectancy and reduce HIV transmission
[140–142]. Earlier HIV diagnosis linked to ART may also have
important socioeconomic effects at the population level, including
(1) reducing the number of orphans [143], (2) improving education
and employment outcomes [144,145], and (3) increasing the size
of workforces [146,147].
The HIV positivity rate among participants in community-
based HTC approaches was generally lower than that among
participants in facility-based HTC. This could be because (1)
symptomatic people with HIV are more likely to visit health
facilities, (2) healthcare workers are more likely to offer HTC to
patients with symptoms that might be associated with HIV, and (3)
the positivity rate of participants in community-based HTC is
more likely to be representative of the general population. While
obtaining a lower positivity rate may immediately be associated
with increased numbers needing to be tested to identify people
with HIV, community-based HTC increased the number of newly
diagnosed people with HIV 4-fold in a randomised controlled trial,
has the potential to decrease HIV stigma by normalising HIV
testing, and is an opportunity to provide prevention interventions
for HIV and other diseases to asymptomatic populations
[23,52,82,137–139]. The HIV positivity rate among key popula-
tions utilising community-based testing varied relative to the HIV
positivity rate among key populations utilising facility-based HTC
and requires further examination within different epidemiological
contexts. Although few comparative cost data exist on the various
HTC approaches, the reported estimates indicate that several
community-based testing approaches are cheaper or similarly
priced compared to facility-based HTC (Table 6).
Because many settings lack universal health coverage, other
disease control strategies—such as the guinea worm eradication
campaign [148], eradication campaigns against polio and measles
[149,150], and efforts to eliminate preventable blindness [151]—
are built upon community-based elements for broader reach.
Since community outreach efforts for these disease control
Figure 13. First time testers in community-based testing approaches for key populations.
doi:10.1371/journal.pmed.1001496.g013
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strategies have largely been vertical in nature, some have suggested
leveraging community-based HTC as a conduit for delivering
other public health activities based on national burden of disease
[152]. Multi-disease approaches may include the provision of
vaccines, water filters, and malaria bed nets and screening for
cardiovascular disease, diabetes, and pulmonary disease [153].
Settings implementing recent WHO guidance on community-
based screening for tuberculosis and malaria could also consider
multi-disease frameworks to improve efficiency [154,155]. Includ-
ing other public health activities based on national epidemiology,
such as family planning and viral hepatitis screening and
treatment, may also be appropriate. Indeed, 40 of the 117 studies
meeting this review’s eligibility criteria (34%) had a multi-disease
component. Broadening community-based HTC to include
preventive interventions and screening for other diseases could
further improve cost-effectiveness [156].
In the studies reviewed, HTC uptake exceeded 80% in the
mobile, index, self, and door-to-door testing approaches. While
workplace and school-based testing could be an important
approach in some settings, the uptake of these approaches was
lower than that of other community-based approaches. Further
research may improve their acceptability and could evaluate their
impact on employment and education outcomes. Although there
was no evidence of any harm resulting from being tested in
community-based HTC approaches, there were reports of fear of
status disclosure or stigma. Moreover, a recent report highlights
the possibility of false positive diagnoses in settings (1) lacking a
confirmation HIV test, (2) with poor training and supervision of
community health workers, and (3) with insufficient quality
control procedures [157]. These findings highlight the continuing
need to adhere to validated testing algorithms and to address
legal and human rights issues, and for the 5 Cs of good testing
Figure 14. Pooled percentage of community-based HTC participants with CD4 counts above 350 cells/ml.
doi:10.1371/journal.pmed.1001496.g014
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practices—informed consent, confidentiality, counselling, correct
test results, and connection to prevention and care—to always be
present [10].
There was variable uptake for community-based testing among
key populations. The heterogeneity between studies likely relates
to differences in the way HTC was offered. For example, the
studies with the lowest uptake among key populations offered
HTC only in combination with extensive behavioural surveys
[92,95]. The findings from this small number of studies cannot be
generalised widely. Moreover, there were limited CD4 count and
ART linkage data from these studies, indicating that caution may
be needed when providing HTC to key populations in settings
where they remain marginalised and stigmatised and where there
are inadequate linkages to prevention and care services. It is also
important to safeguard confidentiality and prevent possible
coercion, discrimination, and other adverse consequences for key
populations being offered HTC in community settings. Further
operational research on community-based testing for key popula-
tions, including mobile peer-based models [120,133,158,159],
within this human rights framework is needed.
One of the benefits of community-based testing, especially door-
to-door testing, is allowing couples and families to be counselled
about their HIV status, behaviour change, ART, and prevention
interventions together [160,161]. Review of population-level HTC
efforts suggest that implementation of community-based HTC
could increase the number of couples receiving testing (Table 2).
There were relatively limited data on HTC approaches for infants,
children and adolescents. The door-to-door, mobile, school, and
index community-based approaches have promise for these young
populations, but further research could improve their operationa-
Figure 15. Linkage to care with community-based approaches to HTC. Asterisk: study included 14 workplace sites in the Democratic
Republic of Congo, Rwanda, Burundi, Congo, and Nigeria.
doi:10.1371/journal.pmed.1001496.g015
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lisation [43,44,87–89,102,103,128]. In addition to implementing
provider-initiated HTC in all health facilities in generalised
epidemics, introducing HIV testing at scheduled immunisation
visits may facilitate earlier diagnosis linked to care [162].
Offering community-based HTC in addition to facility-based
HTC increased knowledge of HIV status approximately 7-fold at
the population level. Providing near universal knowledge of HIV
status linked to prevention and care may impact HIV transmission
networks through increased coverage of ART, increased male
circumcision prevalence, increased utilisation of needle exchange
programmes, increased utilisation of condoms, increased utilisa-
tion of pre-exposure prophylaxis, behavioural change, and
increased coverage of opiate substitution therapy. A cluster-
randomised trial detected a statistically non-significant 14%
reduction in population incidence in communities where commu-
nity-based HTC was available [130]. Since community-based
HTC wasn’t directly linked to prevention and care services in this
trial, achieving and maintaining high levels of HTC coverage and
maximising linkage to ART and other components of combination
prevention could lead to more substantial reductions in population
incidence [163–165].
Incidence reductions depend on high coverage of repeat testing
among people at risk of HIV infection. WHO recommends that
HIV-negative individuals with ongoing sexual behaviour and/or
who inject drugs with partners of positive or unknown HIV status
should be tested at least annually [166]. A high percentage of
people reported being first-time testers with community-based
approaches, and overall there was a higher proportion of first-time
testers in community-based approaches than in facility-based
approaches. In effective HTC programmes, the proportion of
people reporting receiving their first test should decrease over time
as a result of implementing WHO repeat testing recommendations
[25]. Several studies assessed uptake in the context of repeat
testing. In several generalised epidemic settings, uptake remained
high among the general population [24,25]. Conversely, uptake
decreased among the general population in a concentrated
epidemic, suggesting that HTC may need to be targeted to key
populations on an ongoing basis in these settings [26].
This review found that 80% of participants in the community-
based HTC studies where CD4 measurement was offered had
their CD4 count measured after HIV diagnosis. CD4 measure-
ment was facilitated by (1) point-of-care CD4 diagnostics, (2)
collection of blood samples at the time of diagnosis, and (3)
workplace programmes that had regular contact with participants
because of their work schedules. This percentage was similar to the
percentages reported in two systematic reviews evaluating CD4
measurement from facility-based testing (59%–72%) [167,168],
and supports the notion that high uptake of CD4 measurement
can be achieved outside of health facilities when it is offered in
combination with testing results. This review also found that 73%
of participants initiated ART after their CD4 counts indicated
that they were eligible. This proportion was comparable to
previous estimates from two systematic reviews evaluating ART
initiation rates from healthcare facilities (62%–68%) [167,168].
Linkage from community-based HTC approaches to community-
based treatment programmes could improve ART access and
uptake and merits further exploration [169–171]. The data on
linkage to prevention services, including linking men with
negative results to male circumcision [57], were very limited.
These linkages will be required to maximise the population
benefits of community-based testing. Additional data on linkage
to prevention services are urgently needed. Because self-testing
achieves anonymous knowledge of status, no studies have been
able to provide data on rates of linkage to care or prevention for
people using this testing approach [172]. Nonetheless, self-testing
may provide programmatic advantages in some settings and
requires further research [173].
There are some methodological limitations that need to be
considered when evaluating the impact of community-based
HTC. One of the outcomes, first-time tester proportion, has
potential for recall bias since it relies on participants to recall their
history of HIV testing. Since all of the studies that included a
facility-based HTC comparator arm did not indicate whether
HTC was provider- or client-initiated, comparisons were made to
facility-based HTC approaches irrespective of who initiated the
interaction. Therefore, this review may not provide conclusive
Table 5. Community coverage of voluntary HTC.
Study (Testing Approach) Duration (Months) Country Year Number Tested Number Eligible
Percent
Coverage
Sweat (mobile) [23] 42 Thailand 2007 10,464 11,290 93%
Lugada (mobile) [56] 0.23 Kenya 2008 47,173 51,178 92%
Chamie (mobile) [51] 0.16 Uganda 2007 4,343 6,300 69%
Wolff (door-to-door) [81] 1 Uganda 2001 1,078 1,591 68%
Naik (door-to-door) [70] 16 South Africa 2010 5,086 7,614 67%
Kimaiyo (door-to-door) [63] 7 Kenya 2009 90,062 143,284 63%
Negin (door-to-door) [71] — Kenya 2008 1,984 3,180 62%
Sweat (mobile) [23] 42 Zimbabwe 2007 6,579 10,700 61%
Tumwesigye (door-to-door) [74] 30 Uganda 2007 264,966 — 52%
Sweat (mobile) [23] 37 Tanzania 2007 2,832 6,250 45%
Sweat (facility-based) [23] 42 Thailand 2007 2,721 10,033 27%
Sweat (facility-based) [23] 37 Tanzania 2007 685 6,733 10%
Sweat (facility-based) [23] 42 Zimbabwe 2007 610 12,150 5%
Wolff (facility-based) [81] 12 Uganda 2000 79 1,591 5%
—, data not reported.
doi:10.1371/journal.pmed.1001496.t005
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evidence of community-based HTC relative to provider-initiated
HTC. While 73% of participants initiated ART after their CD4
count indicated they were eligible, all of the studies providing these
data did not provide information on the timing of this outcome.
Understanding how soon after diagnosis participants were able to
initiate ART could help establish the efficiency of linkage systems.
While this review summarises information from different commu-
nity-based testing approaches globally, only six of the 117 studies
identified were from Asia, indicating a need to expand commu-
nity-based HTC research efforts in this region. Finally, given the
complexity and expense of conducting cluster-randomised con-
trolled trials, most of the studies meeting the eligibility criteria
were observational. Although our analyses included data from
randomised controlled trials, the potential for unmeasured
confounding in observational studies makes attempts to establish
causal effect more difficult.
The meta-analyses may have limitations in the statistical
methodology used. Using the I2 statistic, there was high
heterogeneity for most meta-analyses. All analyses should be
interpreted with respect to local epidemiology, social and cultural
context, and the health systems organisation of the studies
contributing data. Publication bias was not formally assessed, as
analytical methods to test for publication bias, such as funnel plots
and funnel plot asymmetry tests, may not be appropriate for
observational data [174]. Multiple study estimates and standard-
ised variable definitions are required to explore the contributors of
heterogeneity for pooled estimates. Given that the same variables
were not collected systematically in all studies, this assessment was
not undertaken for this review.
In conclusion, many community-based approaches achieved
high uptake of HTC. Costs and linkage to care appeared similar
to those of facility-based HTC approaches. The lower yield of
people with HIV relative to facility-based HTC approaches
appears to be offset by increasing knowledge of status at the
population level, which, combined with timely linkage to
treatment and prevention services, could have population effects
on life expectancy and HIV transmission. As countries develop
their new national strategic plans and investment cases based on
WHO and Joint United Nations Programme on HIV/AIDS
strategic guidance [175], consideration should be given to
increasing the proportion of people with HIV who know their
status, with linkages to prevention and care, by offering
community-based testing in addition to facility-based testing
[176].
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Protocol S1 Systematic review protocol.
(PDF)
Table S1 Search strategy for all databases.
(PDF)
Table S2 Newcastle-Ottawa Quality Assessment Scale.
*Given that the distribution of possible confounders in randomised
controlled trials is related to chance alone, randomised controlled
trials were not assessed for confounding.
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criteria. CE model, cost-effectiveness model; N/A, not applica-
ble (e.g., gender data was not calculated for community-based
testing only for MSM or FSW); N/R, not reported; OS,
observational study; RCT, randomised controlled trial; STD,
Table 7. Pooled relative risks of community- versus facility-based HTC sensitivity analyses.







Uptake 10.65 (6.27–18.08) 96.1% [43] 13.99 (11.75–16.68) N/A
Proportion of first-time testers 1.23 (1.06–1.42) 99.8% [27,29,107,108,111] 1.12 (0.91–1.38) 99.9%
HIV positivity rate 0.59 (0.37–0.96) 99.6% [27,29,43,62,87,108,119–121] 0.47 (0.22–1.02) 99.6%
Coverage 7.07 (3.52–14.22) 99.7% [81] 5.71 (2.63–12.40) 99.8%
N/A, not applicable.
doi:10.1371/journal.pmed.1001496.t007
Table 8. Pooled uptake proportion sensitivity analyses.





Index 88.2 (80.5–95.9) 99.7% [30] 93.5 (89.1–97.9) 99.0%
Mobile 86.8 (85.6–88.1) 99.9% [26,52,53] 97.9 (97.6–98.3) 98.5%
Door-to-door 80.0 (76.9–83.1) 99.9% [30,68,77,79,81] 84.2 (81.8–86.6) 99.9%
Workplace 67.4 (32.8–100.0) 100% [86] 76.9 (61.8–92.0) 99.8%
School 62.1 (39.6–84.5) 99.0% [87] 71.9 (46.4–97.3) 99.4%
Outliers were defined as study estimates more than one standard deviation away from the pooled estimate.
doi:10.1371/journal.pmed.1001496.t008
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sexually transmitted disease; TB, tuberculosis; VCT, voluntary
counselling and testing.
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Editors’ Summary
Background. Three decades into the AIDS epidemic, about
34 million people (most living in resource-limited countries)
are infected with HIV, the virus that causes AIDS. Every year
another 2.2 million people become infected with HIV, usually
through unprotected sex with an infected partner, and about
1.7 million people die. Infection with HIV, which gradually
destroys the CD4 lymphocytes and other immune system
cells that provide protection from life-threatening infections,
is usually diagnosed by looking for antibodies to HIV in the
blood or saliva. Disease progression is subsequently moni-
tored in HIV-positive individuals by counting the CD4 cells in
their blood. Initiation of antiretroviral drug therapy—a
combination of drugs that keeps HIV replication in check
but that does not cure the infection—is recommended when
an individual’s CD4 count falls below 500 cells/ml of blood or
when he or she develops signs of severe or advanced
disease, such as unusual infections.
Why Was This Study Done? As part of intensified efforts
to eliminate HIV/AIDS, United Nations member states
recently set several HIV-related targets to be achieved by
2015, including reduced transmission of HIV and increased
delivery of antiretroviral therapy. These targets can only be
achieved if there is a large expansion in HIV testing and
counseling (HTC) and increased access to HIV prevention and
care services. The World Health Organization currently
recommends that everyone attending a healthcare facility
in regions where there is a generalized HIV epidemic
(defined as when 1% or more of the general population is
HIV-positive) should be offered HTC. However, many people
rarely visit healthcare facilities, and others refuse ‘‘facility-
based’’ HTC because they fear stigmatization and discrimi-
nation. Thus, facility-based HTC alone is unlikely to be
sufficient to enable national and global HIV targets to be
reached. In this systematic review and meta-analysis, the
researchers evaluate the performance of community-based
HTC approaches such as index testing (offering HTC to the
sexual and injecting partners and household members of
people with HIV), mobile testing (offering HTC through a
service that visits shopping centers and other public
facilities), and door-to-door testing (systematically offering
HTC to homes in a catchment area). A systematic review uses
predefined criteria to identify all the research on a given
topic; meta-analysis combines the results of several studies.
What Did the Researchers Do and Find? The researchers
identified 117 studies (most undertaken in Africa and North
America) involving 864,651 participants that evaluated
community-based HTC approaches. Among these studies,
the percentage of people offered community-based HTC
who accepted it (HTC uptake) was 88% for index testing,
87% for self-testing, 80% for door-to-door testing, 67% for
workplace testing, and 62% for school-based testing.
Compared to facility-based approaches, community-based
approaches increased the chances of an individual’s CD4
count being above 350 cells/ml at diagnosis (an important
observation because early diagnosis improves subsequent
outcomes) but had a lower positivity rate, possibly because
people with symptoms of HIV are more likely to visit
healthcare facilities than healthy individuals. Importantly,
80% of participants in the community-based HTC studies
had their CD4 count measured after HIV diagnosis, and 73%
of the participants initiated antiretroviral therapy after their
CD4 count fell below national eligibility criteria; both these
observations suggest that community-based HTC success-
fully linked people to care. Finally, offering community-
based HTC approaches in addition to facility-based ap-
proaches increased HTC coverage seven-fold at the popu-
lation level.
What Do These Findings Mean? These findings show
that community-based HTC can achieve high HTC uptake
rates and can reach HIV-positive individuals earlier, when
they still have high CD4 counts. Importantly, they also
suggest that the level of linkage to care of community-based
HTC is similar to that of facility-based HTC. Although the
lower positivity rate of community-based HTC approaches
means that more people need to be tested with these
approaches than with facility-based HTC to identify the same
number of HIV-positive individuals, this downside of com-
munity-based HTC is likely to be offset by the earlier
identification of HIV-positive individuals, which should
improve life expectancy and reduce HIV transmission at
the population level. Although further studies are needed to
evaluate community-based HTC in other regions of the
world, these findings suggest that offering community-
based HTC in HIV programs in addition to facility-based
testing should support the increased access to HIV preven-
tion and care that is required for the intensification of HIV/
AIDS elimination efforts.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001496.
N The World Health Organization provides information on all
aspects of HIV/AIDS, including information on counseling
and testing (in several languages)
N Information is available from the US National Institute of
Allergy and Infectious Diseases on HIV infection and AIDS
N NAM/aidsmap provides basic information about HIV/AIDS
and summaries of recent research findings on HIV care and
treatment
N Information is available from Avert, an international AIDS
charity, on many aspects of HIV/AIDS, including informa-
tion on the global HIV/AIDS epidemic, on HIV testing, and
on HIV transmission and testing (in English and Spanish)
N The UK National Health Service Choices website provides
information (including personal stories) about HIV and
AIDS
N The World AIDS Day Report 2012 provides up-to-date
information about the AIDS epidemic and efforts to halt it
N Patient stories about living with HIV/AIDS are available
through Avert; the nonprofit website Healthtalkonline also
provides personal stories about living with HIV, including
stories about getting a diagnosis
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